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ABSTRACT 
 
VALIDITY OF BIOIMPEDANCE FOR THE ASSESSMENT OF TOTAL BODY AND 
SEGMENTAL FAT-FREE MASS IN OLDER MEN AND WOMEN AND A 
COMPARISON OF METHODS USED TO CLASSIFY SARCOPENIA 
 
Jordan R. Moon, Ph.D. 
 
The University of Oklahoma, 2009 
 
Supervising Professor: Jeffrey R. Stout, Ph.D. 
 The purpose of the current investigation was to evaluate the validity of several total 
body fat-free mass (FFM), muscle mass (TBMM), water (TBW), and appendicular lean mass 
(ALM) equations in older adults compared to a criterion four-compartment (4C) model and 
dual-energy X-ray absorptiometry (DXA). Additionally, this investigation examined two 
body composition-based methods for the classification of sarcopenia. Seventy-four healthy 
older men (n = 32) and women (n = 42) participated in the investigation (mean ± SD, age = 
72 ± 6 years, height =167.5 ± 8.5 cm, mass = 69.49 ± 12.71 kg). Body composition was 
assessed using bioimpedance analysis (BIA/MFBIA) and spectroscopy (BIS) and compared 
to a 4C model and DXA. Additionally, relative skeletal muscle index (RSMI) and skeletal 
muscle index (SMI) were calculated using DXA and BIA, respectively. In both men and 
women, TBW methods produced low SEE values (< 1.57 kg) and high r values (> 0.92), but 
mean differences were observed (> -2.01 L) compared to deuterium oxide. A BIS-estimated 
TBW two-compartment model produced low SEE values (< 2.17 kg) and high r values (> 
0.88), but mean differences were observed (> -3.71 kg) compared to the 4C model. BIS 
xi 
 
TBMM equations resulted in low SEE values (< 2.28 kg) and high r values (> 0.79), but 
mean differences were observed (> -0.68 kg) in all but one equation for men and women 
combined, and one for the women alone compared to DXA muscle mass values. Equations 
for ALM estimated via BIS resulted in low SEE values (< 2.07 kg) and high r values (> 
0.69), but mean differences were observed (> -1.20 kg) compared to DXA lean mass values. 
A MFBIA device produced low SEE values (< 2.14 kg) and high r values (> 0.77), but mean 
differences were observed (> -0.42 kg) with the exception of lean mass in the legs for men, 
compared to the 4C model and DXA. All BIA FFM equations produced low SEE values (< 
2.29 kg) and high r values (> 0.83), but mean differences were observed (> 1.11 kg) with the 
exception of one equation for all groups and one equation for women only, compared to the 
4C model. Total body muscle mass estimated via BIA resulted in low SEE values (< 2.14 
kg) and high r values (> 0.81), but mean differences were observed (> -0.50 kg). 
Appendicular lean mass BIA and MFBIA produced low SEE values (< 1.68 kg) and high r 
values (> 0.83), but mean differences were observed (> -0.71 kg) with the exception of one 
equation for all groups and the MFBIA in men. Of the ALM equations, one produced valid 
results (r > 0.75, SEE < 0.48) for RSMI compared to DXA. This equation resulted in a total 
accuracy of 91% in all men and women compared to DXA RSMI for the classification of 
sarcopenia. Comparing a TBMM equation that has been used to classify sarcopenia to DXA 
muscle mass, there was a 69% agreement. The BIA-based sarcopenia classification method 
indicated forty-four subjects as sarcopenic, while the DXA-based method only classified 
sixteen as sarcopenic. Total agreement between sarcopenia classification methods was only 
24%. Mean differences suggest corrections are needed for systematic deviations produced by 
nearly all equations. However, there are accurate BIA equations, and more complicated 
MFBIA and BIS equations were no better than these BIA equations. Therefore, BIA is an 
acceptable method to predict both FFM and ALM in older men and women and can be used 
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as an alternative to DXA or a 4C model. Poor agreement between sarcopenia classification 
methods indicates a need for a standardized procedure. Nonetheless, the accurate ALM BIA 
equation used to predict RSMI for use in sarcopenia classification produced an individual 
accuracy of 91%, suggesting that using an ALM equation to predict DXA ALM is more 
appropriate than generating a new BIA-based sarcopenia classification method.  
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CHAPTER I 
INTRODUCTION 
 
By 2050, the number of Americans age 85 and older will be nearly 18 million 
(16). In 2011 the first of 76 million Baby Boomers will turn 65 years of age. By 
2021, this group will reach 75 years of age, the age when healthcare costs start to 
escalate (64), making the ten-year period from 65 to 75 years of age crucial for 
reducing health-related costs and improving the quality of life of aging individuals. 
More importantly, in the fastest growing age group, the Medicare expenditures per 
enrollee for those 85 and older are much higher compared to younger groups (75). 
Specifically, average nursing home costs for individuals aged 85 and older are nearly 
nine times the costs for those aged 69 and 70 (75). While most older adults consider 
themselves to be in good health and live independent lives, the National Advisory 
Council on Aging found that 91% of Canadians had one or more chronic conditions, 
40% lived with a disability, and a large number (10-25%) were considered frail (27). 
Frailty, and other chronic health conditions, can be attributed a decline across 
multiple physiological systems, resulting in a reduction of one’s ability to complete 
tasks of everyday living (25). Recent investigations have determined that 
neuromuscular function is closely associated with these activities of daily living 
(ADL) (34, 58). Therefore, muscular and neuromuscular function contribute directly 
to maintenance of ADLs, as well as to frailty and other chronic health conditions. 
 Muscle fatigue can be defined as the fall in maximum force-generating 
capacity of the muscle (63) and the failure of the muscle to maintain the required 
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force (36). Some experts suggest that “low tolerance for muscular work” could be a 
better indicator of frailty than muscle weakness alone (68, 90). Nonetheless, muscle 
fatigue and frailty together can be associated with factors such as aging, disease, 
inflammation, physical inactivity, malnutrition, hormonal deficiencies, subjective 
fatigue, and neuromuscular function and structure (74). Moreover, strength 
decrements can lead to sarcopenia (muscle loss), which increases the possibility of 
accidental falls in older adults, leading to potential hip fractures and other injuries 
(10, 42). Along with a six-fold increase in government health care costs for the aged 
by 2040, hip fracture costs alone are projected to be six billion dollars in the year 
2040, (65). More importantly, 20% of those with hip fractures will not be able to 
walk (47), and the average individual at 80 years old lacks the muscle capacity to 
rise unassisted from a chair (15). These muscular and injury-related limitations not 
only increase health-related costs but detrimentally affect quality of life, as well as 
the ability to perform ADLs (33). Therefore, due to the direct association between 
sarcopenia-related injuries and the subsequent effects on ADLs and quality of life, 
there exists a need for methods that identify the early onset of sarcopenia, as well as 
a guide to reduce the further development of sarcopenia at its earliest occurrence. 
 Currently, sarcopenia can be defined as a relative skeletal muscle mass index 
(RSMI = appendicular fat-free mass (kg) / height in m2) two standard deviations 
below healthy standards (men < 7.26 kg/m2, women < 5.45 kg/m2) (6). However, the 
calculation of RSMI requires appendicular lean mass assessments from a dual-
energy X-ray absorptiometry (DXA) scanner (6). These scanning devices expose 
individuals to radiation, require a trained technician, and are expensive to purchase 
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and maintain. Another investigation by Janssen et al. (33) suggested classifying 
sarcopenia using a bioelectrical impedance analysis (BIA) total body muscle mass 
(TBMM) equation (32) using a skeletal muscle index (SMI = TBMM / body mass x 
100) with classifications based on between one and two standard deviations (Class I, 
men 31% - 37%, women 22% - 28%), and above two standard deviations (Class II, 
men < 31%, women < 22%) from a normal population. However, neither of these 
methods is considered standard, and the comparison of the two for the classification 
of sarcopenia is not known. Furthermore, the validity of the Janssen et al. (32) 
equation in an older population had not been established for predicting TBMM or for 
the classification of sarcopenia in Americans. The authors (33) simply state that the 
equation was valid compared to magnetic resonance imaging in a wide age range 
(18-86) and adiposity (BMI = 16-48 kg/m2), and the internal cross validation 
produced an r value of 0.93. However, this equation has not been externally 
validated in an older population of Americans. Still, other past methods that have 
been used to identify sarcopenia have included body composition analysis, as well as 
physical functioning tests. Unfortunately, by the time physical function has 
decreased, sarcopenia may have contributed to a significant loss of muscle, thereby, 
increasing the risk for a fall or other related injuries/illnesses. Therefore, the ideal 
method to identify sarcopenia or muscle loss would be to directly assess muscle mass 
MM. However, typical body composition devices that can assess muscle mass (MM) 
or fat-free mass (FFM), such as X-ray computed tomography (CT), magnetic 
resonance imaging (MRI), DXA, air-displacement plethysmography (BODPOD), 
and underwater weighing scanners/apparatuses, are highly expensive and require 
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travel to a testing center. The limitations of these devices are specifically their lack 
of portability and the cost of not only one, but multiple, measurements. 
Imaging devices such as CT, MRI, and DXA are now considered the gold 
standard for estimating segmental MM and volume. Analysis of a series of CT and 
MRI images taken along the human body can provide very accurate measurements of 
body composition. Unfortunately, the high cost and radiation dose associated with 
CT makes this technique impractical for routine or regular body composition 
measurements. Although MRI imaging does not produce radiation, it still remains a 
costly procedure and is unlikely to become a routine screening tool for body 
composition. Currently, the gold standard for total body FFM and fat mass (FM) 
assessment is the four-compartment model, which includes a measurement of bone, 
body water, body volume/density, and body fat. As with the previous models, the 
high cost and technical skill required to utilize this model reduces its practicality. 
Nonetheless, these methods can accurately identify MM and accurately track 
changes in body composition. In fact, the four-compartment model has been 
suggested for use when tracking changes due to its accuracy in several populations 
(49, 50, 53, 87). More importantly, due to individual variations in FFM 
hydration/density and changes in the extracellular water-to-intracellular water ratio, a 
multiple-compartment model that includes a total body water estimation is required 
to accurately predict or track changes in both fat and FFM in older men and women 
(21, 70, 82). Still, a four-compartment (4C) model involves several measurements 
and techniques. Specifically, criterion total body water methods, such as isotope 
dilution, require long equilibration periods and expensive equipment and analysis. 
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However, several field techniques have been developed which claim to rapidly and 
affordably assess MM, FFM, and total body water (TBW).  
Field techniques include bioelectrical impedance analysis (BIA) and 
bioimpedance spectroscopy (BIS). Bioimpedance has become a popular technique 
because in its simplest form it only requires someone to remove his or her shoes to 
get an estimate of FM and FFM. The principle underlying BIA/S is the fact that the 
electrical impedance of FFM and adipose tissue is different. State of the art BIA/S 
systems use multiple electrodes and multiple frequencies to determine body 
composition including water fraction. These multi-electrode systems could 
potentially provide an approximate distribution of both total body and segmental 
MM. However, these devices have not been validated in older adults and, to date, 
there has not been an investigation using the BIA/S segmental electrode placements 
suggested by Kaysen et al. (35) in any population other than hemodialysis patients. 
In addition, there is a lack of evidence to support the use of BIS to predict total body 
water for the potential use in a multiple-compartment model or for predicting fat-free 
and FM using the two-compartment (2C) model of Pace et al. (55). However, 
bioimpedance spectroscopy has been proven to be valid in younger healthy 
populations of men and women and could potentially be used to predict TBW, FFM, 
MM, and FM in older adults (35, 44, 50, 52, 53). In addition, a recent publication 
suggests “a clinical definition of sarcopenia ought to use methods of assessment that 
are valid, reliable, specific to skeletal muscle, predictive of future health events, non-
invasive, practical, low cost and widely accessible” (56). 
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Therefore, if BIA or BIS techniques are found to be valid in an older 
population, these devices could potentially be used for sarcopenia screening in 
nursing homes, hospitals, fitness centers, or in any commercial or clinical 
environment. Furthermore, this type of device would allow for facilities and 
individuals the opportunity to monitor changes in MM, FFM, and FM and potentially 
increase their quality of life allowing for a healthier, longer, and less medically 
expensive life. Additionally, the cost of government funded healthcare due to 
sarcopenia-related illnesses and injuries could dramatically be reduced.  
 
Hypotheses 
1. It is hypothesized that both BIA and BIS devices will result in valid total 
body water estimations compared to deuterium oxide. 
 
2. It is hypothesized that the two-compartment model using total body water 
estimated via BIS will result in larger errors compared to a four-compartment 
model than muscle mass predictions using BIS compared to dual-energy X-
ray absorptiometry muscle mass. 
 
3. It is hypothesized that the BIS muscle mass equations of Tengvall et al. (73) 
will produce more accurate results than the BIS muscle mass equation of 
Kaysen et al. (35) developed in hemodialysis patients. 
 
7 
 
4. It is hypothesized that the segmental BIS equations of Kaysen et al. (35) 
developed in hemodialysis patients would result in good agreement with 
dual-energy X-ray absorptiometry but produce mean differences and 
subsequent large total error values. 
 
5. It is hypothesized that the InBody720 MFBIA would result in good 
agreement with dual-energy X-ray absorptiometry but produce mean 
differences and subsequent large total error values. 
 
6. It is hypothesized that all BIA fat-free mass equations would produce good 
agreement with the four-compartment model but may produce mean 
differences and subsequent large total error values. 
 
7. It is hypothesized that the BIA total body muscle mass equation of Janssen et 
al. (32) developed using magnetic resonance imaging would be less accurate 
than the equation of Tengvall et al. (73) developed using dual-energy X-ray 
absorptiometry. 
 
8. It is hypothesized that the most recent BIA appendicular lean mass equation 
of Macdonald et al. (44) would produce more accurate results than the older 
equation of Kyle et al. (40). 
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9. It is hypothesized that the BIA appendicular lean mass equations would 
produce more accurate relative skeletal muscle index values compared to the 
InBody720 MFBIA and the combination of two segmental equations. 
 
10. It is hypothesized that there will be little agreement between sarcopenia 
classification methods due to the differences in the methods used for 
assessing lean mass. 
 
Definition of Terms 
Appendicular lean mass – The sum of lean mass from both the left and right arms 
and the right and left leg. 
Appendicular muscle mass – The sum of muscle mass from both the left and right 
arms and the right and left leg.   
Relative skeletal muscle index – Calculated using appendicular lean mass divided by 
height in meters squared. 
Skeletal muscle index – Calculated using total body muscle mass divided by body 
mass multiplied by 100. 
 
Abbreviations 
HT – Height (cm) 
BM – Body mass (kg) 
R – Resistance 
Xc – Reactance 
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Ri – Intracellular resistance 
Re – extracellular resistance 
ICW – intracellular water 
ECW – Extracellular water 
BIA – Bioelectrical impedance analysis 
BIS – Bioimpedance spectroscopy 
MFBIA – Multiple frequency bioelectrical impedance analysis 
DXA – Dual-energy X-ray absorptiometry 
TBW – Total body water (L) 
D2O – Deuterium oxide 
r – Pearson product moment correlation coefficient 
SEE – Standard error of estimated 
TE – Total error 
CE – Constant error/mean difference 
LOA – Limits of agreement 
FFM – Fat-free mass 
FM – Fat mass 
TBMM – Total body muscle mass 
MM – Muscle mass 
ALM – Appendicular lean mass 
AMM – Appendicular muscle mass 
RSMI – Relative skeletal muscle index 
SMI – Skeletal muscle index 
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2C – Two-compartment 
4C – Four-compartment 
CT - X-ray computed tomography 
MRI - magnetic resonance imaging 
 
Delimitations 
At least sixty men and women over the age of sixty-five will be recruited for 
this investigation. All subjects will complete a general health history questionnaire 
and a written informed consent prior to all testing sessions. In order to be eligible for 
participation, subjects must be healthy and implant- and pacemaker-free. 
Additionally, all subjects must be ambulatory. 
 
Assumptions 
Theoretical Assumptions 
1. The health history document will be completed accurately. 
2. Subjects will be fasting for a minimum of twelve hours with ad libitum water 
consumption. 
3. Equipment will perform properly. 
4. Proper hydration is accurately reflected in urine specific gravity. 
Statistical Assumptions 
1. Normality – The sample population is evenly distributed. 
2. Independent observations – Each condition is independent of each other. 
3. Equal variances – The variances between variables are equal.  
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Limitations 
1. Subjects will be recruited from Norman, Oklahoma and surrounding areas 
and may not represent all men and women sixty-five and over. Additionally, 
all subjects will be volunteers, so the sample is not a true random selection 
from the population. 
2. Despite the fact that isotope dilution techniques are criterion for predicting 
total body water, there is evidence that indicated the choice of sample and 
isotope may influence the predictions. Therefore, methods using this 
technique may not directly compare to other dilution methods. 
3. The use of air-displacement rather than hydrostatic weighing could also be a 
limitation. While data suggest both methods are valid, hydrostatic weighing 
is considered the gold standard for estimating body volume. 
4. Because subjects are healthy, there is no way of knowing a-priori if any of 
them are sarcopenic. Therefore, there may not be enough sarcopenic subjects 
to make accurate comparisons of methods.  
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CHAPTER II 
REVIEW OF LITERATURE 
  
Over the past several decades, body composition methods have been 
advancing for use in all populations. Improvements include such methods as 
bioelectrical impedance analysis and bioimpedance spectroscopy, as well as 
advancements in four-compartment (4C) models and dual-energy X-ray 
absorptiometry (DXA) technology. One population for which body composition 
assessments are particularly important is older men and women. Specifically, muscle 
mass (fat-free mass) has been shown to decrease with age (22). This loss of muscle 
mass has been termed sarcopenia. Sarcopenia has been associated with a decrease in 
quality of life due to the reduced ability to perform typical activities of daily living 
(33). Therefore, there is a need for an accurate method to estimate the early onset of 
sarcopenia. More importantly, due to the rising number of older adults, the method 
used to estimate muscle or lean mass should be easy to use, cost effective, and 
portable, allowing for assessments in clinics and offices. Unfortunately, the most 
accurate methods for predicting muscle are expensive, time consuming, and not 
portable. Such techniques include magnetic resonance imaging (MRI), DXA, and 
multiple compartment models which use a combination of non-portable methods. 
While some bioimpedance methods are portable and other are not, all bioimpedance 
methods are fast, non-invasive, and simple to perform, suggesting bioimpedance may 
be a useful alternative for predicting muscle mass to more complicated methods. 
However, literature does not agree regarding which bioimpedance methods and 
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equations are valid in older men and women. More importantly, there are multiple 
methods using muscle mass predictions for the classification of sarcopenia. This 
review will focus on bioimpedance methods and equations used in the past to predict 
muscle mass (MM), fat-free mass (FFM), and lean mass in older adults. 
Additionally, this review will discuss two currently acceptable muscle mass-based 
sarcopenia classification methods. 
 
Basic Principles of Bioimpedance 
 Bioimpedance methods are classified by the number of frequencies used for 
analysis. Single frequency devices use “bioelectrical impedance analysis” (BIA), 
while multiple frequency devices use “bioimpedance spectroscopy” (BIS) for 
predicting body composition and fluid volumes. The term spectroscopy is used 
because BIS methods utilize a “spectra” of frequencies. However, the number of 
frequencies needed before a BIA device can be considered a BIS device is unknown. 
Typically, BIS devises utilize Cole modeling (12) and mixture theories (26) rather 
than regression equations to predict body composition variables (45). Therefore, BIA 
devices that use multiple frequencies are typically called “multi-frequency 
bioelectrical impedance analyzers” (MFBIA). However, it has been reported that BIS 
using the Cole model (12) is the “best model” for predicting body composition via 
bioimpedance (45) yet the main principles behind how these devices can be used to 
predict body composition are the same. 
 By sending electrical currents through the body, bioimpedance devices can 
calculate impedance, otherwise known as the resistivity (R) and reactance (Xc) of the 
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current. This is possible because cell membranes in the human body behave as 
capacitors, and impedance to electrical flow is dependent on the frequency of the 
electrical current (12, 23). At low frequencies (< 50 kHz) the electrical current 
cannot penetrate cell membranes and, therefore, can be used to predict extracellular 
water. Higher frequencies (> 50 kHz) can penetrate cell membranes and be used 
estimate intracellular volumes. This basic principle is the foundation for BIA, 
MFBIA, and BIS devices to estimate body composition. However, there is a 
fundamental assumption made by all bioimpedance devices that the human body is 
composed of uniform cylinders. While this is not the case, total body bioimpedance 
can still accurately predict body composition compartments. This is possible because 
the body’s fluid is evenly distributed and body segmental lengths are proportional to 
segmental circumferences (17). BIA devices use a single 50 kHz current to calculate 
the body’s impedance (R and Xc). These values are then used in regression equations 
to predict various body composition compartments. Surprisingly, the use of 50 kHz 
was not intended for predicting body composition, but for tracking changes in 
dialysis patients (54). It has been reported that the BIA technique using 50 kHz is 
“scientifically unsound” (45). Still, 50 kHz remains the standard for BIA devices. 
Typically, body composition equations predict FFM because there is a relative 
constant relationship between total body water (TBW) and FFM (0.68 – 0.74) (84). 
Since the electrolytes in the body’s water are the best conductors of electrical 
current, bioimpedance most accurately predicts fluid volumes. However, TBW 
contains both intracellular water (ICW) and extracellular water (ECW), and a 50 kHz 
frequency may not account for all of the ICW because it may not penetrate cell 
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membranes. In fact, it has been reported that a frequency of 100 kHz cannot 
completely penetrate through a cell (76). Because muscles contain a large portion of 
ICW, bioimpedance methods that utilize higher frequencies are preferred for 
predicting FFM (45, 61).  
Advanced MFBIA devices utilize several frequencies to predict body 
composition compartments. MFBIA devices typically utilize frequencies ranging 
from 5 to 500 kHz, allowing for a more accurate estimate of intracellular and 
extracellular volume compared to single frequency devices. However, MFBIA 
equations are limited by the same assumptions as single frequency devices and are 
also considered inferior to BIS because they do not utilize modeling techniques (45). 
Nonetheless, arguments exist for both BIA and BIS techniques (39, 45, 59, 60). Still, 
BIS is the most comprehensive bioimpedance method, and data support its accuracy 
for predicting fluid volumes and other body composition variables (1, 14, 51, 52, 
79). Bioimpedance spectroscopy is considered superior to BIA and MFBIA because 
the calculation of fluid volumes is not based on equations but on Cole modeling (12) 
and mixture theories (26). However, BIS is subject to the same assumptions as BIA 
and MFBIA. Nonetheless, BIS can calculate resistivity at both an infinite frequency 
and at a frequency of zero. Using these resistance values, intracellular (Ri) and 
extracellular resistance (Re) can be calculated, and subsequent volumes can be 
calculated. However, BIS still uses a constant FFM hydration (0.73) to predict FFM. 
Recently, due to the complexity of the method, BIS has been used to develop 
prediction equations for TBMM. Overall, the appropriateness of BIA, MFBIA, and 
16 
 
BIS for the prediction of total body muscle mass (TBMM), FFM, appendicular lean 
mass (ALM), or TBMM for use in an older population remains unclear. 
 
Fat-Free Mass Equations  
One of the oldest two-compartment models was developed for predicting 
body composition using only TBW (55). Similar to the assumptions of BIA and BIS, 
this method assumes a constant FFM hydration status of 0.732. It has been reported 
that TBW can vary with age (66). A common assumption is that TBW decreases 
with age causing a dehydration of FFM. While some studies support this finding (43, 
72), others suggest the opposite (28, 30, 66, 93). Nonetheless, if hydration remains 
around 0.732, the Pace and Rathbun 2C (55) model using TBW should be accurate. 
A study by Wang et al. (87) found that the 2C model of Pace and Rathbun (55) 
produced slight underestimations (1.04 kg) with an SEE of (0.95 kg) for fat mass 
compared to a six-compartment model. Still, the accuracy of the 2C model of Pace 
and Rathbun (55) is dependent on the ability of BIS to predict TBW. Several studies 
have indicated accurate TBW and FFM predictions in younger populations (1, 14, 
51, 52, 79). However, there is limited, but promising, research using BIS in the 
elderly (73).  
There have been several attempts to predict FFM using BIA in an older 
population (5, 18-20, 41, 62, 88). As early as 1990, BIA equations have been 
developed for older adults (18, 19). Deurenberg et al. (19) developed two equations 
compared to a 2C model (71) using hydrostatic weighing and found good agreement 
(r > 0.91, SEE < 2.85 kg). In the same year, using the same 2C model, Deurenberg et 
17 
 
al. (18) developed another equation with similar results to their earlier investigation 
(r > 0.81, SEE < 3.22 kg). Later, Kyle et al. (41) evaluated this equation and found a 
high r value (0.96) and low SEE (2.4 kg) compared to DXA, yet Kyle et al. (41) 
found a mean difference of 2.9 kg. This mean difference is most likely related to the 
criterion method used, 2C model vs. DXA. One year later Baumgartner et al. (5) 
developed a new BIA equation for predicting FFM in older adults. Like the results 
from the Deurenberg et al. (18, 19) studies, the Baumgartner et al. (5) equation found 
good agreement comparing a BIA FFM equation to a 4C model (r = 0.91, SEE = 
2.51 kg). Several years later, Kyle et al. (41) cross-validated the Baumgartner et al. 
(5) equation with similar findings to the original investigation (r = 0.94, SEE = 2.8 
kg). However, Kyle et al. (41) found a mean difference of -2.9 kg, which is most 
likely due to the criterion method used, 4C model vs. DXA. Similar to the 
Baumgartner et al. (5) study, Williams et al. (88) discovered a good relationship 
between a 4C model and a BIA FFM prediction equation (r > 0.86, SEE < 1.6 kg). 
Another finding by Williams et al. (88) was that the Siri et al. (71) 2C model was no 
different than a 4C model, suggesting the hydration of FFM and the density of FFM 
in older adults are no different than a reference cadaver. Years later, Roubenoff et al. 
(62) found good agreement with a new BIA prediction equation compared to DXA (r 
> 0.84, SEE, < 3.5 kg). Subsequently, Kyle et al. (41) cross-validated the Roubenoff 
et al. (62) equation with similar results in men and women 22 to 94 years of age 
compared to DXA FFM (r = 0.98, SEE = 1.8 kg). However, Kyle et al. (41) found a 
mean difference of 2.6 kg compared to DXA. This mean difference could be related 
to the DXA models used. Kyle et al. (41) used a Hologic QDR-4500, while the 
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Roubenoff et al. (62) study used a GE Lunar DPX-L DXA model. Studies have 
shown that different DXA models may provide different results (77, 78). Kyle et al. 
(41) also developed a new BIA equation in men and women 22 to 94 years of age. 
Compared to DXA, Kyle et al. (41) found good agreement (r = 0.97, SEE = 1.7 kg) 
using the new BIA FFM equation. Another, more recent investigation developed a 
BIA FFM equation using a 4C model that included total body potassium and TBW 
(20). Dey et al. (20) also found good agreement between methods (r 0.95, SEE = 
2.64 kg, LOA ± 5.21 kg). However, this equation was developed in a Swedish 
population of older men and women and has not been evaluated in Americans. 
Overall, the current BIA FFM equations appear to have good agreement with 
whatever criterion method used for development. However, there are mean 
differences between equations when compared to different criterion methods. 
Furthermore, the only investigation that has cross-validated other FFM equations in 
older adults used DXA as a criterion, and to date no investigation has utilized the 
most recent 4C model of Wang et al. (85), with updated soft tissue mineral constants, 
for comparing BIA FFM equations in older adults. 
 
Total Body Muscle Mass Equations 
 In the year 2000, Jansen et al. (32) developed a TBMM BIA equation using 
MRI in men and women 18 to 86 years of age. Results indicated good agreement 
when two separate equations were cross-validated in different laboratories (r > 0.81, 
SEE < 2.8 kg). When the subjects from both laboratories were pooled, the final 
regression equation also produced a good relationship (r = 0.94, SEE = 2.6 and 2.7 
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kg). Recently, the final Janssen et al. (32) equation was evaluated in Swedish and 
Taiwanese populations (11, 73). In Taiwanese older adults, compared to MRI, the 
Janssen et al. (32) BIA TBMM equation produced better agreement than the original 
investigation (r = 0.98, an SEE of 1.56 kg) in Caucasian Americans. However, a 
mean difference of -0.44 kg was observed. Additionally, a significant mean 
difference (men -4.05 kg, women -1.02 kg, p < 0.03) was observed in Swedish older 
adults when the Janssen et al. equation was compared to a DXA MM equation (37). 
Mean differences between investigations could be related to the conflicting 
populations and criterion methods. In hemodialysis patients (33-73 yr), Kaysen et al. 
(35) developed BIS MM equations using MRI as the criterion. Muscle mass 
equations were produced that predict TBMM and segmental MM. Using intracellular 
water as the main predictor variable, Kaysen et al. (35) was able to predict both 
segmental (SEE arms = 0.63 kg, legs = 2.03 kg) and total (r > 0.87, SEE < 3.29 kg) 
body MM with good agreement compared to MRI. To date, the equations of Kaysen 
et al. (35) have not been evaluated in any population. Tengvall et al. (73) used both 
BIS and BIA to predict TBMM estimated by a DXA MM equation (37). Using 
standard BIA variables (resistance and reactance) a TBMM prediction equation 
resulted in a high correlation (r = 0.96, SEE = 1.59 kg) with DXA predicted MM. 
Bioimpedance spectroscopy MM equations produced similar results to the BIA 
equation with (r = 0.96, SEE = 1.60 kg) or without (r = 0.96, SEE = 1.64 kg) body 
mass as a predictor. Unlike the BIS equation of Janssen et al. (32), both BIS 
equations used raw intracellular resistance (Ri) and extracellular resistance (Re) 
rather than converting Ri to ICW. However, when the Janssen et al. (32) equation 
20 
 
was cross-validated in Taiwanese older adults (r = 0.98, an SEE of 1.56 kg), the 
results  were similar to those of the Tengvall et al. (73). Therefore, all TBMM 
equations (BIA and BIS) produced similar predictions compared to DXA MM or 
MRI. Still, the equations of Tengvall et al. (73) have not been validated in another 
lab and the various findings for the Janssen et al. (32) equation warrants further 
investigation.  
 
Multi-frequency BIA (InBody720)  
 To date, there has not been an investigation comparing the InBody720 eight-
polar MFBIA to anything other than DXA in an older population. Recently, Gibson 
et al. (24) compared the percent fat estimates from the InBody720 to a 4C model in 
men and women 18 to 82 years of age. Results from this investigation indicate that 
this method is not valid. Percent fat total error and SEE values were too large to be 
of practical use (> 4.84 kg). Significant (p < 0.05) mean differences were found in 
the women only. Similarly, in the same year, Volgyi et al. (83) found significant 
differences in FFM (p < 0.05) for both men (3.2 kg) and women (3.4 kg) compared 
to DXA. Based on the published research utilizing the InBody720 MFBIA, future 
investigations are needed before this device and method are used in any population. 
Nonetheless, a comparison of FFM values from the InBody720 MFBIA and a 4C 
model is needed. 
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Appendicular Lean Mass Equations 
Currently, there are only two ALM equations, both utilizing BIA. In 2003, 
Kyle et al. (40) developed an ALM equation in healthy men and women 22 to 94 
years of age. Results indicated good agreement between the BIA equation and DXA 
ALM (r = 0.95, SEE = 1.12 kg, CE = 0.1 kg, LOA ± 1.1 kg). Three years later, 
Macdonald et al. (44) cross-validated the equation of Kyle et al. (40) (mean ± SD, 
65.1 ± 12.0) and found a significant (p < 0.001) overestimation of 2.3 kg compared 
to DXA. Additionally, compared to the original study by Kyle et al. (40), Macdonald 
et al. (44) found a lower r value (0.89) and larger SEE value (2.49 kg) compared to 
DXA. Similarly, Tengvall et al. (73) found a significant (p < 0.03) CE of -1.23 kg in 
men and -0.64 kg in women. Therefore, Macdonald et al. (44) developed another 
BIA ALM equation using DXA as the criterion. Similar to the equation of Kyle et al. 
(40), the Macdonald et al. (44) equation produced a high r value (0.96) and a low 
SEE value (1.57 kg). One reason for the dissonant findings could be related to the 
DXA models used. Specifically, both investigations utilized a Hologic DXA but used 
different models and software, and research supports variable findings with different 
software and DXA models (77, 78, 91). To date, the use of BIA ALM prediction 
equations for use in the classification of sarcopenia has not been investigated. 
Additionally, these ALM equations have not been compared to DXA in another lab 
or to different DXA models such as the GE Lunar used by Baumgartner et al. (6) for 
the classification of sarcopenia. 
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Sarcopenia Classification Methods 
Two ALM-based methods are currently being used for the classification of 
sarcopenia. One method uses a relative skeletal muscle index (RSMI) calculated 
using DXA ALM (6). The other method uses a skeletal muscle index (SMI) 
calculated using the Janssen et al. (32) TBMM equation (33). However, both 
methods classify sarcopenia based on deviations from a young healthy population. 
The Baumgartner et al. (6) method considers individuals with RSMI values less than 
two standard deviation below a young healthy population as sarcopenic, while the 
Janssen et al. (33) method classifies sarcopenia into two classes: Class I is defined as 
one to two standard deviations below a young healthy population, and Class II is 
defined as over two standard deviations below a young healthy population. One 
significant difference between methods is the body composition technique used to 
predict ALM. Considering cost, ease of use, and availability, the Janssen et al. (33) 
method is superior to the Baumgartner et al. (6) method. However, there has never 
been a study comparing these methods. Therefore, depending on the method used to 
classify sarcopenia, individuals may or may not be considered sarcopenic. Without a 
standardized classification method, treatments for the sarcopenic cannot be 
suggested with confidence.  
 
Conclusion 
 Currently, research supports the use of BIA equations for predicting FFM in 
older adults. Additionally, BIA TBMM equations appear to be valid in older adults. 
However, there are several new equations that have not been validated or compared 
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to older BIA equations. Furthermore, the validity of BIS equations for predicting 
both segmental and TBMM has not been investigated and warrants additional 
research. The InBody720 MFBIA does not appear to be valid in any population 
studied to date. Additionally, the current classifications of sarcopenia are not 
standardized, and the methods used for calculating these standards have not been 
compared. Future research should investigate new BIA and BIS equations, as well as 
determine the appropriateness of multiple sarcopenia classification methods.   
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CHAPTER III 
METHODS 
Participants 
 Seventy-four healthy (32 men and 42 women) Caucasian older adults (65 and 
older) participated in this investigation. Descriptive characteristics of the subjects are 
presented in Table 1. This study was approved by The University of Oklahoma 
Institutional Review Board for Human Subjects, and all participants completed a 
written informed consent (Appendix E). All participants were ambulatory and not 
using a pacemaker and were considered healthy by evaluating a self-reported health 
history questionnaire (Appendix F). Typical validation studies utilize at least thirty 
participants per group, and several studies in multiple populations have utilized 
fewer subjects than the current investigation and have been published in high-impact 
journals such as Medicine and Science in Sports and Exercise and the Journal of 
Applied Physiology (4, 7, 8, 46, 49, 50, 52, 53, 87, 89). Therefore, the number of 
participants in the current investigation meets or exceeds similar published validation 
studies. 
 
Research Design 
All body composition assessments were performed on the same day in no 
particular order following a twelve-hour fast (ad libitum water intake was allowed up 
to one hour prior to testing). Participants were instructed to avoid exercise for at least 
twenty-four hours prior to testing. Hydration status was determined using specific 
gravity via handheld refractometry (Model CLX-1, precision = 0.001 +/- 0.001, VEE 
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GEE Scientific, Inc. Kirkland, Washington) prior to all body composition 
measurements. Specific gravity values indicated all subjects were properly hydrated 
(>1.004, <1.029) (2, 3). Subject characteristics are presented in Table 1. 
 
Variables 
 Variables were classified as either a predictor or a criterion variable. 
Predictor and criterion variables included the following: total body water (TBW), 
total body fat-free mass (FFM), total body skeletal muscle mass (TBMM), 
appendicular lean mass (ALM), leg muscle mass (MM), arm MM, and relative 
skeletal muscle index (RSMI). Predictor variables were calculated using 
bioimpedance analysis using two devices (Imp™ DF50, and InBody720) and 
bioimpedance spectroscopy using one device (Imp™ SFB7). Criterion variables 
were calculated using deuterium oxide (D2O) a four-compartment (4C) model and 
dual-energy X-ray absorptiometry (DXA). Criterion RSMI was calculated using 
ALM values from DXA, while criterion FFM was calculated using the 4C model. 
 
Bioimpedance Spectroscopy (BIS) 
 Bioimpedance spectroscopy (BIS) was used to estimate muscle mass (MM) 
and FFM following the procedures recommended by the manufacturer (Imp™ SFB7, 
ImpediMed Limited, Queensland, Australia) as reported by Moon et al. (51, 52). 
After resting in a supine position for 5 to 10 minutes, total body water estimates were 
taken while the subjects lay supine on a table with their arms ≥ 30 degrees away 
from their torso with their legs separated. Prior to analysis, each subject’s height, 
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weight, and sex were entered into the BIS device. Each pair of total body electrodes 
was connected by a non-conductive strip allowing for a distance of 5 cm between 
electrode centers. Segmental electrodes were similar in size and shape as the total 
body electrodes with the exclusion of the non-conductive strip. After hair removal 
and cleaning with alcohol, segmental and whole body electrodes were placed on the 
right and left side of the body. Total body electrodes were placed at the wrist (dorsal 
surface at the ulnar styloid process) and ankle (dorsal surface between the malleoli) 
with the connection strip and connected electrode 5 cm distal from the wrist and 
ankle. Segmental electrodes were placed using the locations described by Kaysen et 
al. (35). Using a range of frequencies (1-1000 kHz), the BIS generates complex Cole 
plots in the shape of an inverted “U”, allowing for calculations of the resistance of 
electrical current through the body at both zero and infinite frequencies (45). These 
resistance values are used to calculate extracellular water (ECW) and intracellular 
water (ICW) and summed to equal TBW. Total body water was calculated internal to 
the BIS device using Cole modeling and the Hanai mixture theory (13, 26). 
Coefficients used for men (zero/extracellular = 273.9, infinite/intracellular = 937.2) 
and women (zero/extracellular = 235.5, infinite/intracellular = 894.2) were the same 
used in the investigation by Moon et al. (52). Total body water was used to calculate 
FFM using the two-compartment (2C) model of Pace and Rathbun (55) (Appendix 
A) Previous test retest assessments of 11 men and women measured 24-48 hours 
apart resulted in an SEM = 0.40L, ICC = 0.99 for TBW. Additionally, because 
muscle contains the majority of ICW, ICW and ECW can be used to calculate 
muscle or lean mass (45). The equations of Kaysen et al. (35) and Tengvall et al. (73) 
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were used to calculate TBMM using intracellular resistance (Ri) or Ri and 
extracellular resistance (Re) (Appendix A). The average of two trials was used to 
represent the subject’s Ri, Re, and TBW. Previous test retest assessments of 11 men 
and women measured 24-48 hours apart resulted in an SEM = 49.65, ICC = 0.96 for 
Ri and an SEM = 10.12, ICC = 0.98 for Re. Segmental MM was estimated using Ri 
and the equations of Kaysen et al. (35). Previous test retest assessments of 11 men 
and women measured 24-48 hours apart resulted in an SEM = 33.07, ICC = 0.97 for 
arm Ri and an SEM = 39.27, ICC = 0.88 for leg Ri. 
 
Bioelectrical Impedance Analysis (BIA) 
 Bioelectrical impedance analysis (BIA) was used to estimate lean mass 
following the procedures recommended by the manufacturer (Imp™ DF50, 
ImpediMed Limited, Queensland, Australia; InBody 720, Biospace, Beverly Hills, 
California). The protocol for the Imp™ DF50 was identical to the protocol used for 
the BIS (Imp™ SFB7). However, the frequency used in the Imp™ DF50 was a 
single 50 kHz rather than the range of frequencies for the BIS (1-1000 kHz). No 
prediction equations exist for the prediction of arm or leg muscle or lean mass in 
older adults, so the raw resistance (R) and reactance (Xc) values were used for 
comparison. Total body FFM was estimated using several predictions equations and 
the Imp™ DF50 (Appendix A). Total body muscle mass and ALM were estimated 
using BIA prediction equations and the Imp™ DF50 (Table 2). Previous test retest 
scans of 11 men and women measured 24-48 hours apart resulted in an SEM = 8.91, 
ICC = 0.99 for R and an SEM = 2.55, ICC = 0.74 for Xc. 
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Procedures for the InBody 720 differed from the Imp™ DF50. The InBody 
720 required subjects to stand on a scale with electrodes on the surface of the feet at 
the heel and ball of the foot. After height and age were entered into the device, body 
mass was determined by the built-in scale. Subjects then lightly grasped handles with 
electrodes touching the palms and thumbs separately. Subjects were instructed to 
abduct their arms around 15-20 degrees. Using frequencies at 1, 5, 50, 250, 500, and 
1000 kHz the InBody 720 measured R and Xc and calculated total body and 
segmental body composition values via predetermined manufactures equations 
internal to the device. Output values included FFM, total body muscle mass 
(TBMM), and arm and leg lean mass. Previous test retest scans of 11 men and 
women measured 24-48 hours apart resulted in an SEM = 0.68kg, ICC = 0.99 for 
FFM, an SEM = 0.44kg, ICC = 0.99 for TBMM, an SEM = 0.13kg, ICC = 0.99 for 
arm lean mass, and an SEM = 0.13kg, ICC = 0.99 for leg lean mass. 
 
Air-Displacement Plethysmography  
Body volume determined from air-displacement plethysmography was 
assessed using the BOD POD® (BP), which was calibrated before each test using the 
manufacturer’s instructions with the chamber empty and using a cylinder of known 
volume (49.558 L). Subjects, in spandex shorts and swimming cap only, then entered 
and sat in the fiberglass chamber. The BP was sealed, and the subject breathed 
normally for 20 seconds while body volume (BV) was estimated. After this, the 
subject was connected to a breathing tube internal to the system to measure thoracic 
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gas volume. The subject resumed tidal breathing cycles; a valve in the circuit 
momentarily occluded the airway, during which subject gently “puffed”. This effort 
produced small pressure fluctuations in the airway and chamber that were used to 
determine thoracic gas volume. This value was used to correct body volume for 
thoracic gas volume. All BV measurements were performed by a BOD POD-
certified investigator who had previously demonstrated a SEM of 0.36 liters with an 
ICC > 0.99 for BV in 11 men and women measured 24-48 hours apart. 
 
Deuterium Oxide (D2O) 
Criterion TBW estimations were conducted using D2O (99.8% D2O, 
Cambridge Isotope Laboratories, Inc., Andover, MA, USA) following the standard 
procedures reported by Moon et al. (51, 52). Prior to D2O ingestion, urine samples 
were collected from all subjects. Subjects were instructed to void their bladders as 
much as possible. After voiding the bladder completely, subjects ingested ≈ 11 
grams of 2H along with a 100ml rinse of tap water. The exact amount of D2O 
ingested for each subject was recorded. After a four-hour equilibration period 
subjects were instructed to provide a post-urine sample. Urine-diluted D2O was 
analyzed in triplicate using an isotope-ratio mass spectrometer. Isotope abundances 
in the urine were calculated following the method of Wong et al. (92). TBW was 
then calculated from the dilution of isotopic water and corrected for the exchange of 
D2O with nonaqueous tissue (67). Reliability measurements from 11 men and 
women for D2O in one urine sample measured in triplicate resulted in a SEM value 
of 0.33 L with an ICC > 0.99. 
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Dual-Energy X-ray Absorptiometry (DXA) 
DXA (software version 10.50.086, Lunar Prodigy Advance, Madison, WI) 
was used to estimate total body bone mineral content, total body lean mass, and 
segmental lean mass. Bone mineral content (BMC) was converted to total body bone 
mineral (Mo) using the following equation: Mo = total body BMC x 1.0436 (29). 
Lean mass values were calculated using the DXA software. Each day prior to testing, 
a quality assurance phantom was performed and passed. Before each test, the 
subjects’ height, weight, sex, and race were entered into the computer program. The 
subjects were positioned supine on the DXA table with hands pronated and flat on 
the table. Total body mode was selected for each scan, and scanning thickness was 
determined by the DXA software. All DXA scans were performed by a certified 
enCORETM software operator. The sum of lean soft tissue for both arms and legs 
(ALST) estimated from DXA was used to calculate relative muscle mass index 
[RSMI = appendicular lean mass (kg)/HT(m)2)] and used to classify sarcopenia using 
the standards of Baumgartner et al. (6) (Sarcopenic = RSMI < 7.26 kg/m2 for men, < 
5.45 kg/m2 for women). Additionally, TBMM was estimated using the validated 
equation by Kim et al. (38) (MM = (1.13 x ALST) – 0.02 x age) + (0.61 x sex [men 
= 0, women =1]) + 0.97). Skeletal muscle index (SMI) was calculated using the 
equation reported by Janssen et al. (33) (SMI = TBMM / body mass x 100) and used 
to classify sarcopenia (Class I Sarcopenia, SMI 31% - 37% men, SMI 22% - 28% 
women; Class II Sarcopenia, SMI < 31% men, < 22% women). Previous test retest 
scans of 11 men and women measured 24-48 hours apart resulted in an SEM = 
0.05kg, ICC = 0.99 for Mo, an SEM = 0.605kg, ICC = 0.99 for total body lean mass, 
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an SEM = 0.04kg, ICC = 0.99 for TBMM, an SEM = 0.016kg, ICC = 0.99 for arm 
lean mass, and an SEM = 0.029kg, ICC = 0.99 for leg lean mass.  
 
Four-Compartment Model (4C model) 
 Criterion FFM was estimated using the 4C model described by Wang 
et al. (85). The equation includes measurements of BV, TBW, Mo, and body mass 
(BM). The equations for FM and FFM density are: 
FM (kg) = 2.748(BV) – 0.699(TBW) + 1.129(Mo) – 2.051(BW)  
FFM = BM-FM 
FFM Density = 1/[(TBW/0.9937)+(Mo/2.982)+(Residual/1.404)] (48) 
Residual = BM-BF-Mo-TBW 
 
Propagation of Error 
While multi-compartment models are recommended over 2C models for 
assessing body composition, the potential propagation of errors due to the inherent 
measurement error of each device used to assess each variable may offset the 
improved accuracy of 4C model estimates of body composition (86). Wang et al. 
(86) suggested calculating the propagated error, sometimes referred to as the total 
error of measurement (TEM) (31, 50) to account for the accuracy of the 4C equation. 
The standard errors of measurement (SEM) from the reliability data for the 
measurement of BV, TBW, and Mo were used to calculate propagated errors for 
%fat (86). In the current study, the TEM was 0.49%fat, which is similar (less than 
1%fat) to values reported for the 4C and 5C models in other laboratories (0.70 - 
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0.89%fat) (69, 89). The TEM for the 4C model was calculated from the following 
equation (86): 
4C TEM = (TBW SEM2 + BV SEM2 + Mo SEM2)1/2 
4C TEM = (0.332 + 0.362 + 0.052)1/2 
4C TEM = 0.49 %fat 
 
Statistical Analyses 
Data were analyzed using a custom built LabVIEW Program version 8.2.1 
(National Instruments, Austin, TX, USA) and Microsoft® Excel® 2007 version 
12.0.6504.5001, SP1 MSO 12.0.6320.5000 (Microsoft Corporation Redmond, WA, 
USA). The validity and comparisons of prediction equations was based upon the 
evaluation of predicted values versus the criterion or actual values from D2O TBW, 
the four-compartment model, DXA lean mass, or DXA-derived skeletal muscle mass 
by calculating the constant error (CE = actual – predicted), r value (Pearson product 
moment correlation coefficient), standard error of estimate (SEE), and total error (TE 
= ඥ∑ሾ݌ݎ݁݀݅ܿݐ݁݀ െ ܽܿݐݑ݈ܽሿଶ/݊) (31). The mean differences (CEs = constant errors) 
between criterion and predicted values were analyzed using dependent t-tests with 
Bonferroni alpha adjustments. The method of Bland and Altman was used to identify 
the 95% limits of agreement (LOA) between the criterion and predicted values (9). 
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CHAPTER IV 
RESULTS 
 
Total Body Water 
 Both methods [Bioimpedance spectroscopy (BIS) and the InBody720 multi-
frequency bioelectrical impedance analyzer (MFBIA)] used to predict total body 
water resulted in similar findings (Table 2). Compared to deuterium oxide D2O, BIS 
and the MFBIA produced valid total body estimations. Both methods produced r 
values greater than 0.92 and SEE values less than 1.57 L. All slopes (< 0.909) were 
significantly different (p < 0.05) than the line of identity (slope = 1) with the 
exception of BIS in all subjects. In all subjects, the y-intercept was only significantly 
different (p < 0.05) than zero for BIS (0.982). For both methods, the y-intercept was 
not significantly different (p > 0.05) than zero in the men but was significant in the 
women (y-intercept > 4.9, p < 0.05). All groups produced significant (p < 0.025) CE 
values (> -2.02 L) compared to D2O. Total error values were less for BIS (TE < 2.77 
L) compared to the MFBIA (TE > 3.35 L) for all subjects and the men, while the 
MFBIA produced a lower TE value (TE = 2.84 L) compared to BIS (TE = 2.93) in 
the women. Individual errors, represented by the limits of agreement, were less for 
BIS (< ± 3.04 L) compared to the MFBIA (± > 3.02 L) for all subjects and the men, 
while the MFBIA produced lower LOA’s (± 2.37 L) compared to BIS (± 2.65 L) in 
the women. Significant trends were observed in the women for both methods and for 
the MFBIA in all subjects. 
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Bioimpedance Spectroscopy (BIS) Total Body Equations 
 Results from the total body equations using BIS are presented in Table 3. 
Equation 1 produced high r values (> 0.88) and low SEE values (< 2.17 kg) 
compared to four-compartment (4C) model fat-free mass (FFM) values. However, 
there was a significant CE (p < 0.05) for all groups (CE > -2.89 kg). All y-intercepts 
were significantly different (p < 0.05) than zero. When stratified by sex, equation 1 
produced a slope not significantly (p > 0.05) different than 1. Total error values were 
greater for women (TE = 4.23 kg) compared to the men (TE = 3.62 kg). However, 
the limits of agreement were larger for the men (± 4.33 kg) compared to the women 
(± 4.08 kg). Only the women produced a significant trend (-0.228, p < 0.05).  
 All total body muscle mass (TBMM) equations produced high r values (> 
0.70) and low SEE values (< 2.28 kg). Significant (p < 0.0125) CE values were 
found for all equations for men and women (CE > 0.67 kg) with the exception of 
equation 2 in the women (CE = -0.43 kg). For all equations, slope values were 
significantly different (p < 0.05) for the women but not for the men (p > 0.05) 
compared to the line of identity. Y-intercepts were not significantly different than 
zero for all equations in the men (< 4.2). Equations 2, 3, and 5 produced significant 
y-intercepts in the women compared to a y-intercept of zero. Total errors values were 
lower in the women (TE < 2.40 kg) than the men (TE > 2.25 kg) for all equations 
except for equation 4 (TE men = 2.24 kg, TE women = 3.58 kg) when comparing the 
same equations in men and women independently. Equation 4 produced the tightest 
LOAs for both the men (± 2.97 kg) and the women (± 2.27 kg) compared to 
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equations 2, 3, and 5 (± > 2.66 kg). In women only, equations 2 and 3 produced 
significant trends (> -0.39, p < 0.05). 
 
Bioimpedance Spectroscopy (BIS) Segmental Equations 
 Results from the segmental equations using BIS are presented in Table 4. 
Significant slopes and y-intercepts (p < 0.05) were found for both the arms and legs 
compared to the line of identity and a y-intercept of zero. Significant CE values (p < 
0.05) were found for all groups in the arms and the legs (CE > -1.20 kg) compared to 
dual-energy x-ray absoptiometry (DXA) lean mass values. However, when the arms 
and legs were combined, there was no significant CE for the men (CE = 0.12) 
compared to DXA. The combination of arms and legs (Total AMM) resulted in a 
higher r value for the women (r = 0.78) compared to the legs and arms alone (r < 
0.75). However, the lowest SEE, TE, and CE values were found in the arms 
compared to the legs and Total AMM for the women. The largest r value (r = 0.91) 
and lowest SEE (0.41 kg) and TE (1.43 kg) values were found in the arms for the 
men compared to legs and Total AMM (r < 0.78, SEE > 1.41kg, TE > 1.77 kg). The 
LOAs were the tightest in the arms for both men and women (± < 1.20 kg) compared 
to legs and Total AMM (± > 2.20 kg). However, the arms produced significant (p < 
0.05) trends (> -0.23). 
 
InBody720 (MFBIA) Segmental and Total Body Analysis 
 Results from segmental and total body analyses using the InBody720 MFBIA 
are presented in Table 5. Significant slopes and y-intercepts (p < 0.05) were found 
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for FMM compared to the line of identity and a y-intercept of zero compared to the 
4C model in men and women. In all groups, significant (p < 0.05) CE values were 
discovered for both FFM (> -3.52 kg) and TBMM (> -5.17 kg) compared to the 4C 
model and DXA, respectively. However, both FFM and TBMM produced high r 
values (> 0.84) and low SEE values (< 2.14 kg). TBMM produced tighter LOAs (± < 
3.96 kg) than FFM (± > 3.61 kg) when comparing groups. Significant trends (> 0.07, 
p < 0.05) were found for all groups comparing FFM to the 4C model, while a 
significant trend was found in the women (-0.413, p < 0.05) for TBMM compared to 
DXA. 
 Segmental results produced similar r values (0.78-0.88) for both the arms and 
legs in the men and women compared to DXA. Women produced lower SEE values 
(< 0.62 kg) than the men (SEE > 0.62 kg) in the arms and the legs compared to 
DXA. Total error values were lower in the arms (TE < 0.82 kg) than the legs (TE > 
1.05 kg) for both women and men compared to DXA. Y-intercepts were significantly 
different (p < 0.05) than zero for both arms and legs in both the men and women 
compared to DXA, while slopes were significantly different (p < 0.05) than zero for 
the arms and legs (> 0.535) in the women and in the arms (0.715) for the men 
compared to DXA. For men and women, the LOAs were tighter in the arms (± < 
1.37 kg) than in the legs (± > 1.56 kg) compared to DXA. Significant (p < 0.05) 
trends were found in the women for both arms and legs compared to DXA. 
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Bioimpedance Analysis (BIA) Fat-Free Mass Equations 
 Results from BIA FFM analysis using the DF50 are presented in Table 6. 
Significant slopes and y-intercepts (p < 0.05) were found for equations 8-11 (slopes 
> 0.702, y-intercept > 6.808) for the women compared to the line of identity (y-
intercept of zero, slope of 1) using the 4C model. A significant slope (0.816, p < 
0.05) was also found in equation 12 for the women compared to the 4C model. 
Significant CE values (p < 0.00625) were found in equations 8-14 (CE > 1.83 kg) for 
the men and in equations 8-13 for the women (CE > 1.11 kg). All equations 
produced high r values (> 0.81) and low SEE values (< 3.22 kg) for men and women 
compared to the 4C model. Total error values ranged from 2.20 to 6.84 kg in the men 
and from 1.71 to 4.90 kg in the women compared to the 4C model. The LOAs ranged 
from 3.44 to 6.44 kg in the men and 3.37 to 4.58 kg in the women compared to the 
4C model. Equations 13-15 produced significant trends (>0.125, p < 0.05) for the 
men, and equations 14 and 15 produced significant trends (> 0.285, p < 0.05) for the 
women compared to the 4C model. 
 
Bioimpedance Analysis (BIA) Total Body Muscle Mass Equations 
 Results from BIA TBMM analysis using the DF50 are presented in Table 7. 
Significant slopes and y-intercepts (p < 0.05) were found for equations 16 and 17 
(slopes > 0.633, y-intercept > 2.190) for the women compared to the line of identity 
(y-intercept of zero, slope of 1) using DXA as the criterion. However, equations 16 
and 17 produced higher r values (> 0.89), lower SEE values (< 0.85 kg), lower TE 
values (< 1.42 kg), lower CE values (< -0.64), and tighter LOAs (< 2.52 kg) in 
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women than in men (r < 0.89, SEE > 1.51 kg, TE > 1.97 kg, CE > -1.30, LOA > 
2.93) compared to DXA. Both equations produced significant CE values (p < 0.025) 
in men and women compared to DXA. Equation 17 produced a significant  CE value 
(p < 0.05) in women (-0.361).  
 
Appendicular Lean Mass 
 Results from appendicular lean mass ALM analysis using the DF50 BIA and 
InBody720 BIA are presented in Table 8. Significant slopes and y-intercepts (p < 
0.05) were found for equations 18 and 19 and for the MFBIA (slopes > 0.770, y-
intercept > 2.672) for the women compared to the line of identity (y-intercept of 
zero, slope of 1) using DXA as the criterion. The MFBIA produced significant slopes 
and y-intercepts (p < 0.05) for the men (slopes = 0.774, y-intercept = 5.519) 
compared to the line of identity (y-intercept of zero, slope of 1) using DXA as the 
criterion. Equation 19 produced a significantly different (p < 0.05) y-intercept 
(5.432) compared to a y-intercept of zero using DXA as the criterion. In men and 
women, r values were similar (0.80-0.88). Women produced lower SEE (0.80-0.90 
kg) and TE (0.91-1.58 kg) values than men (SEE = 1.34-1.67 kg, TE = 1.49-5.39 kg) 
compared to DXA. Significant CE values (p < 0.0167) were found using equation 19 
in the men and women (CE > 0.33 kg) and using the MFBIA in the women (CE = -
1.14). The LOAs were tighter in women (< 2.20 kg) than men (> 2.57 kg) compared 
to DXA. The MFBIA produced a significant (p < 0.05) trend in the women (-0.324). 
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Relative Skeletal Muscle Index (RSMI) 
 Results from RSMI predicted using the DF50 BIA, InBody720 MFBIA, and 
SFB7 BIS are presented in Table 9. Significant slopes and y-intercepts (p < 0.05) 
were found for equations 6 +7 (slopes > 0.541, y-intercept > 1.977) in the men and 
women, and for equation 18 (slopes 0.683, y-intercept = 1.737) and the InBody720 
(slopes = 0.613, y-intercept = 1.924) in the women compared to the line of identity 
(y-intercept of zero, slope of 1) using DXA as the criterion. Additionally, equation 
19 produced a significantly different (p < 0.05) y-intercept (1.189) compared to a y-
intercept of zero using DXA as the criterion. In the men and women, r values were 
similar (0.67-0.80). However, SEE values were lower in the women (0.33-0.35 
kg/m2) than in the men (0.47-0.58 kg/m2) compared to DXA. Total error values 
ranged from 0.50 to 1.78 kg/m2 in the men and from 0.36 to 1.19 kg/m2 in the 
women. Significant CE values (p < 0.0.125) were observed in equation 19 in the men 
(CE = 1.72 kg/m2) and equations 19 (CE = 0.14 kg/m2), 6+7 (CE = -1.101 kg/m2), 
and the MFBIA (CE = -0.42 kg/m2) for the women. The LOAs were tighter for the 
women (0.66 to 0.91 kg/m2) than the men (0.91 to 1.14 kg/m2) compared to DXA. 
Significant trends (p < 0.05) were observed in equations 18 (0.294), 19 (0.397), and 
using the MFBIA (0.415) for the men and in equation 6+7 (-0.366) for the women 
compared to DXA.  
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Accuracy of Relative Skeletal Muscle Index (RSMI) and Skeletal Muscle Index 
(SMI) Predictions 
 Accuracy of RSMI predictions used to identify sarcopenia estimated via the 
DF50 BIA, InBody720 MFBIA, and SFB7 BIS are presented in Figures 1-3. Of the 
seventy-four subjects, sixteen were classified as sarcopenic using the RSMI 
classifications (6). In both men and women, equation 17 was the most accurate and 
correctly classified 94% of the subjects with sarcopenia and incorrectly classified 3% 
of the subjects as sarcopenic when they were not based on DXA values. Equation 18 
produced the same 94% accuracy as equation 17 but misclassified 34% of the 
subjects as sarcopenic. The InBody720 correctly classified 44% of the subjects with 
sarcopenia and misclassified 2% of the subjects. The combination of equations 6 and 
7 was 25% accurate at classifying sarcopenia and misclassified 3% of the subjects 
without sarcopenia. 
Accuracy of SMI predictions used to identify sarcopenia estimated via the 
DF50 BIA and DXA are presented in Figures 4-6. Of the seventy-four subjects, 
forty-four were classified as sarcopenic using the SMI classifications of Janssen et al. 
(33). Comparing the Kim et al. (38) DXA-based TBMM equation to the Janssen et 
al. (32) BIA-based TBMM equation as the criterion, DXA correctly classified 95% 
of the subjects who were considered either class I or class II sarcopenic (n = 44). 
However, DXA was incorrect in 27% of the subjects, classifying them as sarcopenic 
when the Janssen et al. (32) BIA-based TBMM equation did not classify them as 
sarcopenic. DXA reported a total accuracy of 69% in all subjects compared to the 
Janssen et al. (32) equation. Of the forty-four classified as sarcopenic by the Janssen 
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et al. (33) standards, eleven were also classified as sarcopenic using the RSMI 
classifications (6) indicating an 18% agreement between methods when calculated 
from all sixty subjects who were classified by both methods combined (Figure 7). 
Additionally, including the agreement between non-sarcopenic subjects, the total 
agreement between methods for classifying non-sarcopenic and sarcopenic subjects 
was 24%, indicating that less than one out of four individuals with or without 
sarcopenia would be classified by both methods. 
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CHAPTER V 
DISCUSSION 
 
Total Body Water 
 In accordance with our hypothesis, both the SFB7 bioimpedance 
spectroscopy (BIS) and the InBody720 MFBIA resulted in valid total body water 
(TBW) estimations compared to deuterium oxide (D2O). The results of the current 
study suggest that both methods are valid laboratory methods for predicting TBW in 
older men and women. However, the SFB7 BIS produced greater accuracy in the 
men while the MFBIA was more accurate in the women. To the best of our 
knowledge, this is the first investigation to evaluate TBW estimations in older adults 
using either the BIS or the MFBIA. Still, in agreement with previous literature in 
various populations, both methods produced high r values > 0.92 and low SEE 
values (< 1.57 L) (51, 52, 57, 80, 81). Surprisingly, both methods in the current 
investigation produced lower SEE values (0.96 – 1.56 L) and higher r values (0.93 – 
0.98) compared to the studies by Moon et al. (51, 52), which used the SFB7 to 
predict TBW in healthy, overfat, and obese young (18 – 44 yr) men and women 
(SEE = 1.50 – 2.89 L, r = 0.70 – 0.98). In contrast to the investigation by Moon et al. 
(52) in non-overweight or obese subjects using the SFB7 BIS, the current 
investigation produced significant (p < 0.025) constant error (CE) values (> - 2.01 L) 
estimated via the SFB7 BIS and the InBody720 MFBIA. Specifically, both devices 
overestimated TBW compared to D2O. These findings are similar to the investigation 
by Moon et al. (51), which found the SFB7 BIS overestimated TBW in overfat and 
43 
 
obese men and women (CE > -1.98 L). Still, compared to the investigations by Moon 
et al. (51, 52) (LOA = > ± 4.17 L in men, > ± 3.67 L in women), the current study 
produced tighter limits of agreement (LOA = < ± 3.49 L in men, < ± 2.66 L in 
women). These findings could partially be explained by the fact that TBW errors 
increase with an increase in body mass (BM) (51). Specifically, the subjects in the 
current investigation had lower BM values (mean 69.49 kg) compared to the 
investigations by Moon et al. (50, 51) (mean BM = 72.8 kg and 82.45 kg). However, 
the slight difference in body weight may not account for all the improvements in 
TBW prediction accuracy. The complete explanation for the improved LOAs and 
SEE values remains unclear. It is hypothesized that there may be less resistivity 
variability between older adults compared to younger adults. Specifically, younger 
populations may have more diverse resistivity constants accounting for greater 
individual variability. However, more research is needed to determine why older 
adults produce less individual variability when predicting TBW via BIS or a MFBIA 
compared to younger healthy adults. Additionally, there was a significant 
overestimation in TBW for both devices suggesting mean resistivity constants are 
not the same as in younger populations. However, since the r values were high and 
the SEE values were low, correcting for these mean differences would allow for 
more accurate TBW estimations for both devices. Specifically, TBW estimated by 
the BIS in older men should be adjusted by subtracting 2.02 L and by subtracting 
2.61 L for the women. Similarly, the MFBIA TBW estimations should be adjusted 
by subtracting 3.52 L in men and 2.58 L in women. While there is a lack of literature 
utilizing the current methods used to predict TBW in older adults, the current results 
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support the use of these methods. Recently, it has been suggested that BIS and 
MFBIA devices that use raw impedance values to calculate TBW should use TBW 
adjusted equations rather than developing resistivity coefficients for every population 
(51). This is particularly important considering total body resistivity can vary with 
age, sex, ethnicity, and body mass (51). Still, more research is needed to identify the 
dissonant findings compared to younger adults. Nonetheless, both methods appear to 
be valid for use in older men and women, and correcting for the CE values for each 
device may produce more accurate results. Furthermore, if ease of use is important, 
the InBody720 MFBIA is suggested, while the SFB7 BIS is suggested if portability 
is desired.  
 
Bioimpedance Spectroscopy (BIS) Total Body Equations 
 In accordance with our hypothesis, total body fat-free mass (FFM) estimated 
using the Pace and Rathbun (55) equation and TBW predicted via the SFB7 BIS 
resulted in larger errors than comparing muscle mass equations to DXA muscle 
mass. However, FFM predicted by the SFB7 BIS resulted in high r values (> 0.88) 
and low SEE values (< 2.17 kg) acquiring subjective ratings of “ideal” for both men 
and women (31). Still, a significant (p < 0.05) CE was observed for both the men (-
2.90) and women (-3.70) resulting in TE values with subjective ratings of “good” for 
the men and “poor” for the women (31). Since the equation of Pace and Rathbun 
(55) is based on TBW and the constant FFM hydration status of 0.732, variations in 
this ratio and inaccurate TBW estimations could have accounted for the significant 
CE values. However, since one-sample t-tests revealed no significant (p > 0.18) 
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differences between 0.732 and the hydration status of FFM for men (mean ± SD, 
0.7354 ± 0.0176) or women (mean ± SD, 0.7339 ± 0.0158), the significant CE values 
are most likely due to inaccurate TBW estimations. Due to the known 
overestimations in TBW when using the SFB7 BIS in an older population, as 
discussed above, correcting for the CE values when using this method to predict 
TBW should reduce the TE and CE values when converting TBW to FFM. However, 
when the two-compartment model (2C) of Pace and Rathbun (55) using D2O was 
compared to a four-compartment (4C) model, CE values ranged from -0.14 kg for 
men and -0.46 kg for women (89); Yet this study used a FFM hydration status of 
72% not 73.2%. Nonetheless, due to the known individual errors when predicting 
TBW via the SFB7 BIS, the accuracy of FFM predictions using the equation of Pace 
and Rathbun (55) will always be less than when using dilution techniques. Still, if 
the CE values can be corrected the accuracy of this technique would be considered 
“ideal”. Specifically, subtracting 2.90 kg from FFM in the men and subtracting 3.70 
kg for women, the Pace and Rathbun (55) 2C model would be an acceptable method. 
However, more research is required before this method is suggested for use in older 
men and women. 
 Contrary to our hypothesis, the BIS-based elderly population specific muscle 
mass equations of Tengvall et al. (73) resulted in larger errors than the muscle mass 
equations developed in hemodialysis patients by Kaysen et al. (35). To the best of 
our knowledge, this is the first investigation to validate equations 2-5 in an older 
population that was not used to develop an equation. Results indicated that the 
equations of Tengvall et al. (73) were more accurate than the equations of Kaysen et 
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al. (35) in women but not in the men. Specifically, the Tengvall et al. (73) equations 
(2 and 3) produced TE values less than 1.70 kg in the women, and equation 2 was 
not significantly different than dual-energy X-ray absorptiometry (DXA) muscle 
mass (MM) estimations, while equations 2 and 3 produced TE values over 4.16 kg in 
the men and both equations produced significant (p < 0.0125) CE values (>3.76 kg). 
Furthermore, equations 2 and 3 produced lower SEE values in the women (< 0.85 
kg) than in the men (> 1.72 kg). These results suggest that equations 2 and 3 are 
appropriate for use in women but not for men. Of equations 2 and 3 in the women, 
equation 2, utilizing BM, produced the most accurate TBMM predictions and the 
tightest agreement (± 2.67 kg). Dissonant findings for the men could be related to the 
BIS device used and the method for calculating intracellular resistance (Ri) and 
extracellular resistance (Re). Specifically, past literature has shown that different BIS 
devices produce variable results (52). However, since the same device was used for 
the women, who produced accurate results, the inaccurate findings in the men may 
be related to other factors. Another factor could be related to the DXA TBMM 
equation used. While equations 2 and 3 were developed using an equation of Kim et 
al. (37), the authors used a more recent but less complex model than the model used 
in the current investigation. Nonetheless, equations 2 and 3 were accurate in women, 
so the criterion method may not be the only reason for the inaccuracy of these 
equations in the men. It is hypothesized that both the device used and the criterion 
method affected the outcome of the men’s results. Still, if the CE values could be 
corrected in the men, equations 2 and 3 may produce accurate results; yet, based on 
the SEE values (< 1.84 kg), equations 2 and 3 may not be as accurate in men as they 
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are in women. More research is needed before either equation 2 or 3 is suggested for 
use in older men. Equation 2 is suggested for use in older women. 
 Equations 4 and 5, developed in hemodialysis patients (33-73 yr), 
compared to magnetic resonance imaging (MRI), produced low SEE values (< 1.94 
kg) for both men and women. Total error values were less (< 2.85 kg) than equations 
2 and 3 (> 4.16 kg) for the men but resulted in significant (p < 0.0125) CE values (> 
3.76 kg). However, equation 4, based on intracellular water (ICW) only produced an 
SEE of 1.54 kg, which is over half as low as in the original equation (SEE = 3.28 
kg). Furthermore, equation 5 produced an SEE of 1.93 kg which is slightly greater 
than in the original equation (SEE = 1.85 kg). Still, both equations 4 and 5 
significantly (p < 0.0125) underestimated TBMM by more than 2.12 kg. However, 
due to the low SEE values, correcting for the CE values could produce accurate 
estimations in older men. Nonetheless, more research is needed before equations 4 or 
5 are suggested for use in older men or women. 
 
Bioimpedance Spectroscopy (BIS) Segmental Equations 
 In accordance with our hypothesis, segmental BIS analysis revealed low SEE 
(< 1.68 kg) values, large TE values (> 1.42 kg), and significant (p < 0.05) CE values 
(> 1.20 kg). To the best of our knowledge, this is the first investigation to compare 
the segmental BIS equations of Kaysen et al. (35) in older adults. Compared to the 
original investigation (SEE arms = 0.63 kg, legs = 2.03 kg), SEE values were lower 
in both men (arms = 0.41 kg, legs = 1.42 kg) and women (arms = 0.31 kg, legs = 
0.92 kg). However, r values were lower in the legs for both men (0.69) and women 
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(0.70) and in the arms for the women (0.74), compared to the original investigation (r 
= 0.83) of Kaysen et al. (35). Still, considering the original investigation developed 
equations 6 and 7 in non-hemodialysis patients (33-73 yr), the current results support 
the validity of equations 6 and 7 in non-hemodialysis populations. However, 
corrections for significant CE values should be made. In the current population, arm 
TBMM was underestimated while leg MM was overestimated. When the arms and 
legs were combined to equal appendicular MM, in men, equations 6+7 were more 
accurate than alone and produced no significant (p > 0.05) CE (0.12 kg) with an SEE 
of 1.67 kg and a TE of 1.78 kg compared to appendicular lean mass (ALM) 
estimated by DXA. Yet this was not the case in women; the combination of 
equations 6+7 resulted in an increased SEE (0.99) compared to the arms (0.31 kg) 
and legs (0.92 kg) alone. Nevertheless, individual errors represented by the LOA 
were larger when equations 6 and 7 were summed compared to each equation alone. 
Therefore, segmental analysis alone is preferred over summing the arms and legs. 
However, the sum of equations 6 and 7 may produce accurate appendicular muscle 
mass (AMM) estimation in older men but not older women. Still, more research is 
needed before equations 6 or 7 are suggested for use in place of DXA in older men 
or women. Nonetheless, the current population produced lower SEE values in both 
men and women for both arms and legs compared to the original investigation. 
Therefore, adjusting the current ICW-based segmental MM equations for specific 
populations, or developing new ICW-based segmental MM equations may allow for 
more rapid assessments of MM and potentially be used in place of DXA. However, 
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the appropriateness of equations 6+7 for the classification of sarcopenia based on the 
relative skeletal muscle index (RSMI) standards remains unclear. 
 
InBody720 (MFBIA) Segmental and Total Body Analysis 
 In accordance with our hypothesis, the InBody720 MFBIA produced 
significant CE values and low SEE values. With the exception of leg lean mass in the 
men (CE = 0.26 kg), all estimations resulted in significant (p < 0.05) CE values 
ranging from -0.29 to -5.23 kg. Significant overestimations were observed from all 
estimations with significant CE values. To the best of our knowledge, this is the first 
investigation to evaluate the InBody720 FFM estimates in an older population using 
a 4C model as criterion. However, investigations have been done using a wide range 
of ages (24, 83). An investigation by Gibson et al. (24) evaluated the InBody720 in 
men and women 18 to 82 years of age compared to a 4C model. However, Gibson et 
al. (24) only evaluated percent fat and not FFM. Still, results indicated much larger 
SEE values (> 4.83% fat) similar to a FFM SEE value greater than 4 kg (31). 
Additionally, Gibson et al. (24) reported no significant difference between methods 
for men (CE = 0.23 %fat, p > 0.05) and a significant difference for women (CE = 
2.99 %fat, p < 0.05), which is similar to the current investigation (CE = -0.29 to 
05.23, p < 0.05). Accurate percent fat values would provide accurate FFM values, 
thus, the discrepancies are not based on the data reported but other factors. Factors 
that may have contributed to discrepancies could include the age range used (18 to 
82 yr), 4C model used, and varying ethnic groups. Specifically, the InBody720 does 
not use regression equations that include body weight, sex, age, or ethnicity. Volgyi 
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et al. (83) (37-79 yrs) compared a Tanita scale and the InBody720 to DXA and found 
differences between scales and between the InBody720 and DXA. Significant 
differences (p < 0.05) were reported in both men (3.2 kg) and women (3.4 kg) for 
FFM compared to DXA for the InBody720. These findings are similar to the FFM 
CEs in the current investigation (4.56 kg in men and 3.53 kg in women). 
Additionally, the current investigation and the investigation by Volgyi et al. (83) 
discovered significant overestimation by the InBody720. Furthermore, the authors 
determined that age and sex were factor in the dissonant findings between the 
InBody720 and the Tanita scale. When age and sex were adjusted for, there was no 
difference between the two devices (83). These findings suggest that sex- and age-
adjusted equations for the InBody720 may provide more accurate estimations of 
FFM. In addition, the current study found large TE (> 5.30 kg) and CE (> 5.17 kg) 
values comparing the InBody720 TBMM values to DXA TBMM values. However, r 
values were high (> 0.84) and SEE values were low (< 1.71 kg) and considered 
“ideal” (31). These data suggest a systematic deviation between the InBody720 and 
DXA TBMM values using the Kim et al. (38) TBMM equation, and correcting for 
these deviations (CE values) may reduce the errors between methods. However, 
more research is needed before the InBody 720 can be recommended for predicting 
TBMM in older men or women. Still, the current investigation found low SEE, TE, 
and CE values for both men and women for the arms and legs lean mass compared to 
DXA. These data suggest that, although the InBody720 may not be valid at 
estimating FFM compared to a 4C model or TBMM compared to the DXA-based 
TBMM of Kim et al. (38), the InBody720 is a valid method for predicting segmental 
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lean mass. Specifically, the InBody720 may be an alternative method for predicting 
RSMI and classifying sarcopenia. However, further investigation is required before 
the InBody720 is suggested as an alternative to DXA for classifying sarcopenia. 
 
Bioimpedance Analysis (BIA) Fat-Free Mass Equations 
 In agreement with our hypothesis, in both men and women, all equations 
produced high r values (> 0.83) and low SEE values (< 3.22 kg) producing 
subjective ratings of “ideal” to “good” for the men and “ideal” to “very good” for 
women (31). Additionally, in agreement with our hypothesis, several equations 
produced significant CE values (p < 0.00625) and large TE values (1.71 – 6.84 kg). 
The most accurate equation (equation 15) was the only equation to produce non-
significant (p > 0.00625) CE values and TE values (men 2.20 kg, women 1.71 kg) 
considered “ideal” (31). Surprisingly, equation 15 was developed using DXA as the 
criterion model. In agreement with the original investigation (r > 0.84) by Roubenoff 
et al. (62) our results produced similar r and SEE values (r > 0.88). However, our 
results produced lower SEE values (< 2.2 kg) than the original investigation (< 3.5 
kg) (62). In agreement with the current SEE values, Kyle et al. (41) found an SEE of 
1.8 kg when utilizing equation 15 in men and women 22 to 94 years of age compared 
to DXA FFM. Of equations 8 and 9 reported by Deurenberg et al. (19), equation 8 
produced lower TE values (< 2.80 kg) compared to equation 9 (SEE > 4.13 kg). 
However, our results for both equations 8 and 9 produced similar r and SEE values (r 
> 0.86, SEE < 2.29) compared to the original investigation (r > 0.91, SEE < 2.85 kg). 
Still, significant (p < 0.00625) CE values were present, indicating a systematic 
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underestimation of FFM. Significant CE values could be explained by the criterion 
method used to predict FFM. Specifically, equations 8 and 9 were developed based 
on a 2C model (71), which assumes constant hydration status, bone mineral content, 
and FFM density. Nonetheless, if the CE for equations 8 and 9 are adjusted for the 
current population, these equations could potentially be used in older men and 
women. Similarly, equation 10 was developed using the same 2C model (71) and 
produced high r values (> 0.81) and low SEE values (< 3.22 kg) consistent with the 
original investigation (r = 0.96. SEE = 2.5 kg) (18). In agreement with the current 
findings, Kyle et al. (41) discovered a high r value (0.96) and low SEE (2.4 kg) 
comparing equation 10 to DXA. Kyle et al. (41) also found a significant CE (2.9 kg) 
with equation 10, which is consistent with the current results (CE 1.69 – 1.84 kg). 
Equation 11 also produced similar values (r 0.84 – 0.9, SEE 2.00 – 2.71 kg) to the 
original investigation (r = 0.91, SEE = 2.51 kg) (5), as well as the investigation by 
Kyle et al. (41) (r = 0.94, SEE = 2.8 kg). Both the current investigation (CE -1.91 - -
4.35 kg) and the investigation by Kyle et al. (41) (CE = -2.9 kg) indicated equation 
11 overestimates FFM compared to either a 4C model or DXA. However, equation 
12, developed by Kyle et al. (41), produced the largest CE values (-5.39 to -6.53 kg) 
in the current sample of older men and women. Still, the current r (0.89 – 0.99) and 
SEE (1.69 – 2.01 kg) values were consistent with the internal cross validation by 
Kyle et al. (41) (r = 0.97, SEE = 1.7 kg). Though, other than the current 
investigation, the final regression equation (equation 12) has not been validated 
internally or externally in any population. A more recent equation (equation 13) by 
Dey et al. (20) was developed using a 4C model. With the exception of significant (p 
53 
 
< 0.00625) CE values (- 2.35 to -4.32) the current investigation (r 0.88 – 0.98, SEE 
1.74 – 2.19 kg, LOA ± < 4.38 k) produced more accurate estimations of FFM than 
the original investigation (r 0.95, SEE = 2.64 kg, LOA ± 5.21 kg) (20). Significant 
CE values could be explained by the different 4C models used and different 
populations. Specifically, Dey et al. (20) utilized a 4C model consisting of total body 
potassium and TBW, while the current investigation utilized a more resent model 
utilizing TBW, bone mineral content, and body volume. Additionally, equation 13 
was developed in a Swedish population of older men and women and the current 
study utilized an American population. Still, equation 13 can be considered valid if 
the systematic deviations (CEs) are adjusted. However, more research is needed 
before equation 13 can be suggested for use in older American men and women. 
Another study utilizing a 4C model to predict FFM using BIA produced similar 
findings to the current investigation (88). Equation 14 produced high r values (> 
0.87) and low SEE values (< 1.86 kg) comparable to the original investigation (r = 
0.96 men, 0.87 women; SEE = 1.5 men, 1.5 kg women) (88). A nonsignificant (p > 
0.00625) CE was observed in the women (-0.72 kg) but not in the men (3.71 kg). In 
addition, women produced a TE value (1.71 kg) considered “ideal”, while men 
produced a TE value (4.10 kg) considered “fairly good” (31). Nonetheless, in the 
men, equation 14 has the tightest LOAs (± 3.44 kg). These data suggest that equation 
14 is a valid alternative to a 4C model in older women and could possibly be a valid 
method in men if the systematic deviations (CEs) are adjusted. However, more 
research is needed before equation 14 can be suggested in older men. Overall, all 
equations for women (± 3.64 – 4.58 kg) had tighter LOAs than the same equations in 
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men (± 4.06 – 6.44 kg), though all equations produced acceptable SEE values for 
both men and women, suggesting equations 8-15 could potentially be used in older 
men and women with more research. Currently, only equation 15 for older men and 
women and equation 14 for women are suggested for use over more complicated 
FFM methods such as a 4C model, 2C model, or DXA. 
 
Bioimpedance Analysis (BIA) Total Body Muscle Mass Equations 
 Contrary to our hypothesis, equation 16, developed using MIR, predicted 
TBMM more accurately than equation 17, developed using DXA TBMM, compared 
to DXA TBMM for both women and men. Equation 16 produced a higher r value 
(0.98), lower SEE (1.17 kg) and TE (1.50 kg) value, a lower CE value (-0.86 kg), 
and tighter LOAs (± 2.44 kg), than equation 17 (r = 0.95, SEE = 2.13 kg, TE = 2.77 
kg, CE = 1.14 kg, LOA ± 4.98 kg). Not surprisingly, when the investigators who 
developed equation 17 (73) compared equation 16 to their population using DXA, 
there was a significant CE (men -4.05 kg, women -1.02 kg, p < 0.03) in both men 
and women. Similarly, the current results showed a significant CE (men 3.45 kg, 
women -0.63 kg, p < 0.03) in both men and women for equation 17. Still, the current 
findings (r = 0.95, SEE = 2.13 kg) are similar to the original investigation for 
equation 17 (r = 0.96, SEE = 1.59 kg) (73). Discrepancies in these findings could be 
related to the DXA TBMM equation used and the population used. The study by 
Tengvall et al. (73) for equation 17 utilized a slightly different equation by Kim et al. 
(37) compared to the current investigation (38) and sampled subjects from a Swedish 
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population not American. Nonetheless, results for equation 17 indicate validity in 
older women and potential validity in older men, with a CE correction.   
 More extensive research has been conducted using equation 16 (11, 33, 73). 
Specifically, the original investigation (32) utilized two separate laboratories for 
equation development. However, the final prediction equation was not validated until 
recently in Swedes and Taiwanese (11, 73). Compared to the original investigation (r 
= 0.94, SEE = 2.6 and 2.7 kg), equation 16 produced similar results compared to 
DXA TBMM in the current investigation (r = 0.98, SEE = 1.17 kg). Similar to the 
findings from equation 16, equation 17 produced more accurate results than the 
original investigation. However, results from Chien et al. (11) were more comparable 
to the current findings. Chien et al. (11) found a CE of -0.44 kg, an r value of 0.98, 
an SEE of 1.56 kg, and LOAs approximately ± 3 kg comparing equation 16 to 
magnetic resonance imaging, which are similar to the current results in all subjects (r 
= 0.98, SEE = 1.17 kg, LOAs ± 2.44 kg). Both equations 16 and 17 appear to be 
valid in women, while only equation 16 appears to be valid in men. However, 
equation 17 could potentially be valid in men if the systematic deviation (CE) is 
corrected. Still, more research is needed before equation 17 is suggested for use in 
older men. 
 
Appendicular Lean Mass 
 Contrary to our hypothesis, the more recent equation of Macdonald et al. (44) 
(equation 19) produced less accurate appendicular lean mass (ALM) predictions 
compared to the original BIA ALM equation of Kyle et al. (40) (equation 18). 
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Validity statistics from equation 18 provided comparable results to the original 
investigation (40). Current results indicated an r value of 0.98, an SEE of 1.21 kg, a 
CE of 0.15 kg and, LOAs of ± 2.4 kg, which are similar to the Kyle et al. (40) 
findings (r = 0.95, SEE = 1.12 kg, CE = 0.1 kg, LOA ± 1.1 kg). However, 
Macdonald et al. (44) found that equation 18 overestimated ALM significantly (p < 
0.001) by 2.3 kg and produced a lower r value (0.89) and larger SEE value ( 2.49 kg) 
compared to the original investigation and the current results. In agreement with 
Macdonald et al. (44), Tengvall et al. (73) found a significant (p < 0.03) CE of -1.23 
kg in men and -0.64 kg in women. Considering these findings, the Macdonald et al. 
(44) equation (equation 19) should have produced dissonant findings compared 
equation 18. This was the case; equation 19 had a significant (p < 0.0167) CE for all 
subjects (2.46 kg), men (5.23 kg), and women (0.34 kg). Still, equation 19 produced 
a similar r value (0.96) and SEE value (1.57 kg) compared to the current findings (r 
= 0.94, SEE = 1.91 kg) for all subjects, suggesting systematic deviations in equation 
19 are the main contributing factor to the lack of agreement between with the 
subjects in the present study. Nonetheless, equation 19 could potentially be used for 
classifying sarcopenia if the accuracy of RSMI is acceptable. Segmental lean mass 
values from the InBody720, as stated earlier, were found to be valid in men and 
women. However, the InBody720 MFBIA results for ALM were found to be valid in 
men only compared to DXA. These results suggest that classifying sarcopenia based 
on RSMI predicted using the InBody720 MFBIA may not be valid. 
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Relative Skeletal Muscle Index (RSMI) 
 To date, this is the first investigation to compare methods for predicting 
RSMI based on BIA-based ALM predictions in older men and women. In 
accordance with our hypothesis, the most accurate ALM equation produced the most 
accurate RSMI predictions. Equation 18 was the most valid for predicting RSMI and 
ALM compared to equations 19 and 6+7 and DXA ALM. More specifically, 
equation 18 resulted in no significant (p > 0.0125) CE values (< 0.21 kg/m2) for all 
subjects, men, or women. Individual errors (LOAs) were less than ± 0.92 kg/m2). 
Still, equations 19, 6+7, and the InBody720 had high r values (> 0.73), low SEE 
values (< 0.77 kg/m2), low TE values (< 1.79 kg/m2), low CE values (< 1.73 kg/m2), 
and low LOAs (< ± 1.75 kg/m2). However, the impact of these errors on sarcopenia 
classifications is not known. 
 
Accuracy of Relative Skeletal Muscle Index (RSMI) and Skeletal Muscle Index 
(SMI) Predictions 
 Accuracies of RSMI and SMI predictions are presented in Figures 1-8. 
Compared to DXA RSMI, equation 18 was the most accurate at classifying 
sarcopenia with a total accuracy of 91% in all the subjects, 100% for the men, and 
85% for the women (Figure 3). The next best equation was 19 with an overall total 
accuracy of 60% in all subjects, 71% in women, but only 3% in men. The 
InBody720 was less accurate than equations 18 and 19, and equations 6+7 were less 
accurate than all equations. These data suggest that equation 18 could be used as an 
alternative to DXA for classifying sarcopenia in older men and women with an 
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accuracy of 91% in men and women. However, equations 19, 6+7, and the 
InBody720 are not accurate enough for the classification of sarcopenia. Regarding 
SMI predictions, since equation 16 has been used to classify sarcopenia, the accuracy 
of the Kim et al. (38) DXA-based TBMM equation was used to calculate SMI and 
compared to the SMI values from equation 16. Total accuracy comparing these 
methods was less (< 73%) than using RSMI and equation 18. Therefore, the Kim et 
al. (38) DXA-based TBMM equation cannot be used as an alternative for equation 
16. However, equation 16 was not developed using DXA but using MRI, and the 
appropriateness of using the more complex method of DXA in place of BIA is 
nonsensical. Nonetheless, these data support the idea that TBMM values differ 
between techniques and cannot be used interchangeably for the classification of 
sarcopenia. Currently, there are currently two accepted body composition-based 
methods for the classification of sarcopenia in older American men and women: 
using the Janssen et al. (32) BIA equation to predict TBMM and then calculating 
SMI; or calculating RSMI using DXA and incorporating the Baumgartner et al. (6) 
standards. However, to date, no investigation has discerned how well these methods 
compare for the classification of sarcopenia. Figures 7 and 8 illustrate the agreement 
between classification methods. Using the Janssen et al. (33) standards from BIA-
predicted TBMM, the number of subjects classified as sarcopenic was over double 
that of the DXA-based ALM Baumgartner et al. (6) standards, suggesting the 
Baumgartner et al. (6) approach is much more conservative than the Janssen et al. 
(33) BIA method. More importantly, only 11 subjects were classified as sarcopenic 
by both methods, indicating only an 18% agreement between the two. Total 
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agreement between both methods (sarcopenic and non-sarcopenic) was only 24%. 
Therefore, the above methods for classifying sarcopenia cannot be used 
interchangeably, and, due to the variations between methods, accurate classifications 
of sarcopenia warrant further research.  
 
Conclusion 
 All methods and equations resulted in low SEE values and high r values. 
Several equations produced significant mean differences and are not suggest for use 
in older men or women without more research. However, based on regression 
analysis, data support the potential validity for all equations in this population. 
Definitively, equations 2, 15, 16, 17, and 18, as well as the InBody720 MFBIA for 
arms and legs, are the preferred methods in women, and equations 15 and 18, as well 
as the InBody720 MFBIA for arms and legs, are preferred in men. While it was not a 
focus of the current investigation, we thought it would be interesting to compare 
DXA FFM values to the 4C model. Significant (p < 0.00001) overestimations (CE -
1.15 to -2.06 kg) were discovered for all groups, but high r values (> 0.91) and low 
SEE values (< 1.73 kg) were observed. Equation 15 produced more accurate TE 
(1.71 to 2.20 kg) values than DXA (TE = 1.78 to 2.66 kg) for all groups compared to 
the 4C model. Nonetheless, DXA produced lower LOAs (< ± 3.32 kg) and SEE 
values (< 1.72 kg) than all BIA FFM equations, indicating DXA is a valid method 
for estimating FFM in older adults but may overestimate FFM by one to two 
kilograms. Considering cost, radiation exposure, time, and training, equation 15 is 
suggested for use in older men and women over DXA for the estimation of FFM. 
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However, the ability of DXA and equation 15 to track changes in FFM warrant 
further investigation. 
Overall, the most accurate method and equation for both men and women 
was using the DF50 BIA and the ALM equation of Kyle et al. (40) (equation 18). 
Conveniently, this equation allowed for accurate calculations of RSMI allowing 
equation 18 to classify sarcopenia with a total accuracy of 91% in both men and 
women compared to using RSMI based on DXA ALM. Therefore, if the sarcopenia 
classifications of Baumgartner (6) are of interest, utilizing BIA equation 18 allows 
for an accurate, portable, fast, and economical alternative to DXA. Sarcopenia 
classification methods are not interchangeable and may result in differing 
classifications. At best, both methods agreed only 28% of the time with a total 
agreement of 24%. Currently, there is no ideal method for classifying sarcopenia, 
and more research is needed before individuals can be considered sarcopenic. 
Because the two accepted methods used in this investigation do not agree, utilizing 
either of these methods in a clinical setting is premature. However, tracking changes 
in RSMI or SMI may provide valuable feedback during an exercise or nutrition 
intervention. Still, more research needs to be conducted to evaluate the 
appropriateness of either method for tracking changes in muscle mass and 
subsequent sarcopenia status in older men and women. 
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Appendix B. 
 
Table 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
Variable Mean SD 
All Subjects (n = 74)     
Age (y) 72 6 
Body weight (kg) 69.49 12.71 
Height (cm) 167.5 8.5 
TBW/FFM (%) 73.48 1.76 
FFM Density (g/cc) 1.105* 0.007 
Men (n = 32)     
Age (y) 72 5 
Body weight (kg) 80.24 9.24 
Height (cm) 175.0 6.0 
TBW/FFM (%) 73.54 1.90 
FFM Density (g/cc) 1.105* 0.006 
Women (n = 42)     
Age (y) 72 6 
Body weight (kg) 61.31 8.01 
Height (cm) 161.5 5.0 
TBW/FFM (%) 73.39 1.58 
FM Density (g/cc) 1.106* 0.007 
 
Descriptive characteristics of subjects, FFM 
Density compared to 1.100 g/cc, p < 0.001 
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Table 6 continued 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Appendix D.  
FIGURE LEGENDS 
 
Figure 1. Percent of correctly identified sarcopenic subjects comparing appendicular 
lean mass equations to DXA using the relative skeletal muscle index classification 
method. Equations numbers are in parentheses. 
 
Figure 2. Percent of incorrectly identified sarcopenic subjects comparing 
appendicular lean mass equations to DXA using the relative skeletal muscle index 
classification method. Equations numbers are in parentheses. 
 
Figure 3. Total accuracy in percent of identified sarcopenic subjects comparing 
appendicular lean mass equations to  
DXA using the relative skeletal muscle index classification method. Equations 
numbers are in parentheses. 
 
Figure 4. Percent of correctly identified sarcopenic subjects comparing total body 
muscle mass equations to DXA muscle mass using the skeletal muscle index 
classification method. Equations numbers are in parentheses. 
 
Figure 5. Percent of incorrectly identified sarcopenic subjects comparing total body 
muscle mass equations to DXA muscle mass using the skeletal muscle index 
classification method. Equations numbers are in parentheses. 
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Figure 6. Total accuracy in percent of identified sarcopenic subjects comparing total 
body muscle mass equations to DXA muscle mass using the skeletal muscle index 
classification method. Equations numbers are in parentheses. 
 
Figure 7. Number of sarcopenic subjects classified by both the relative skeletal 
muscle index and the skeletal muscle index classification methods. 
 
Figure 8. Total percent of agreement between the relative skeletal muscle index and 
the skeletal muscle index sarcopenia classification methods. 
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